mdl 19660 has been researched along with protriptyline in 1 studies
| Studies (mdl 19660) | Trials (mdl 19660) | Recent Studies (post-2010) (mdl 19660) | Studies (protriptyline) | Trials (protriptyline) | Recent Studies (post-2010) (protriptyline) |
|---|---|---|---|---|---|
| 5 | 0 | 0 | 230 | 22 | 28 |
| Protein | Taxonomy | mdl 19660 (IC50) | protriptyline (IC50) |
|---|---|---|---|
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.0049 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dudley, MW; Kane, JM; Miller, FP; Sorensen, SM | 1 |
1 other study(ies) available for mdl 19660 and protriptyline
| Article | Year |
|---|---|
2,4-Dihydro-3H-1,2,4-triazole-3-thiones as potential antidepressant agents.
Topics: Animals; Antidepressive Agents; Desipramine; gamma-Aminobutyric Acid; Male; Mice; Monoamine Oxidase Inhibitors; Norepinephrine; Rats; Rats, Inbred Strains; Structure-Activity Relationship; Triazoles | 1988 |